Stockscreener 앱 받기
2.30
1.29%
-0.03
시간 외 거래:
2.30
전일 마감가:
$2.33
열려 있는:
$2.36
하루 거래량:
1.88M
Relative Volume:
0.49
시가총액:
$356.77M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-2.1495
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
-6.88%
1개월 성능:
-0.43%
6개월 성능:
-49.56%
1년 성능:
-69.54%
1일 변동 폭
$2.29
$2.42
1주일 범위
$2.28
$2.49
52주 변동 폭
$1.15
$9.79
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.30 | 383.14M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
What drives Humacyte Inc. Equity Warrant stock priceFree Stock Selection - Autocar Professional
What analysts say about Humacyte Inc. stockFree Stock Market Query - Autocar Professional
Humacyte Inc. Equity Warrant Stock Analysis and ForecastTriple-digit wealth increases - Autocar Professional
Is Humacyte Inc. Equity Warrant a good long term investmentFree Trend-Following Techniques - jammulinksnews.com
What analysts say about Humacyte Inc. Equity Warrant stockHigh-yield investments - jammulinksnews.com
Is Humacyte Inc. a good long term investmentFree Consultation - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
What drives Humacyte Inc. stock priceSkyrocketing returns - jammulinksnews.com
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - MSN
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders - ACCESS Newswire
Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026 - MSN
Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today - MSN
Lobbying Update: $10,000 of HUMACYTE lobbying was just disclosed - Nasdaq
Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
Positive week for Humacyte, Inc. (NASDAQ:HUMA) institutional investors who lost 56% over the past year - simplywall.st
Humacyte's Symvess ECAT Approval: A Strategic Play for Dominance in Vascular Trauma and Beyond - AInvest
Humacyte’s Symvess gains DOD electronic catalog listing approval By Investing.com - Investing.com South Africa
Humacyte's Symvess ECAT Listing: A Strategic Catalyst for Biotech's Comeback - AInvest
Humacyte stock soars after Symvess gains DOD electronic catalog listing By Investing.com - Investing.com India
Humacyte stock soars after Symvess gains DOD electronic catalog listing - Investing.com Australia
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday - inkl
Humacyte stock up on ECAT listing for Symvess (HUMA:NASDAQ) - Seeking Alpha
Humacyte Announces Symvess ECAT Approval from U.S. Defense Logistics Agency - MarketScreener
Humacyte's Symvess Approved for Listing in US Defense Logistics Agency's Electronic Catalog - MarketScreener
Humacyte’s Symvess gains DOD electronic catalog listing approval - Investing.com
Military Healthcare Win: Humacyte's Symvess Now Approved for Defense and Veterans Affairs Facilities - Stock Titan
Beat the Market the Zacks Way: Humacyte, Starbucks, Oracle in Focus - Yahoo Finance
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - MSN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders - ACCESS Newswire
Humacyte, Inc.(NasdaqGS: HUMA) added to Russell 2500 Value Index - MarketScreener
Humacyte, Inc. (HUMA): A Strategic Entry Point Amid Earnings Momentum and Analyst Optimism - AInvest
Humacyte, Inc. (HUMA): Riding Earnings Momentum Amid Volatility - AInvest
Comparing Functional Patency of Acellular Tissue Engineered Vessel With AVF - Docwire News
Humacyte, Inc. (HUMA): A Shareholder-Driven Biotech Play with Insider Backing - AInvest
Humacyte, Inc. (HUMA) Gains As Market Dips: What You Should Know - sharewise.com
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):